<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Article Point &#187; Diabetes</title>
	<atom:link href="http://www.articlepoint.org/category/health-fitness/diabetes/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.articlepoint.org</link>
	<description>You have questions! We have articles!</description>
	<lastBuildDate>Mon, 25 Jul 2011 20:19:27 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Generex shares soar on preliminary clinical results of oral spray insulin</title>
		<link>http://www.articlepoint.org/generex-shares-soar-on-preliminary-clinical-results-of-oral-spray-insulin/</link>
		<comments>http://www.articlepoint.org/generex-shares-soar-on-preliminary-clinical-results-of-oral-spray-insulin/#comments</comments>
		<pubDate>Fri, 15 Jul 2011 07:19:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[glucose tolerance]]></category>
		<category><![CDATA[insulin response]]></category>
		<category><![CDATA[phase 3]]></category>
		<category><![CDATA[technology company]]></category>

		<guid isPermaLink="false">http://www.articlepoint.org/generex-shares-soar-on-preliminary-clinical-results-of-oral-spray-insulin/</guid>
		<description><![CDATA[8th Jul 2011, 12:00 pm by Deborah Sterescu Drug technology company Generex Biotechnology Corp (OTC: GNBT) rocketed more than 44% &#111;&#110; Friday &#097;&#102;&#116;&#101;&#114; the company announced extremely encouraging preliminary results &#102;&#114;&#111;&#109; two phase 3 clinical trials testing the newest formulation of Generex Oral-lyn, designed &#097;&#115; an oral, or spray meal-time insulin for diabetics. The &#102;&#105;&#114;&#115;&#116; [...]]]></description>
		<wfw:commentRss>http://www.articlepoint.org/generex-shares-soar-on-preliminary-clinical-results-of-oral-spray-insulin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

